$1,000 in Bristol-Myers Squibb Company in 2023 → $1,109 today
If you'd invested $1,000 in Bristol-Myers Squibb Company (BMY) on January 1, 2023 — at the December 2022 month-end close of $60.94 — and held to the latest close (2026-08-), you'd have $1,109. That's a +10.9% total return — trailing the S&P 500, where the same $1,000 became $2,008.
Nearby years: 2019 · 2020 · 2021 · 2022 · 2024 · 2025 · 2026 all years →
FAQ
How much is $1,000 invested in BMY in 2023 worth today?
$1,000 invested in Bristol-Myers Squibb Company (BMY) at the month-end close of 2022-12- would be worth $1,109 at the latest month-end close (2026-08-), a total return of +10.9% with dividends reinvested.
Did $1,000 in BMY in 2023 beat the market?
Over the same span, $1,000 in the S&P 500 index would be worth $2,008 — so Bristol-Myers Squibb Company (BMY) trailed the index by +44.7%.
What does "month-end close" mean for this calculation?
The scenario invests at the December 2022 month-end close (the price entering 2023) and values the position at the most recent month-end close (2026-08-). Intra-month extremes are shown on the BMY calculator page.
Is the 2023–2026 return in BMY typical?
No single year is typical. BMY's best calendar-year return since 1972 was about +77.1%, and its worst was -52.4%.
Methodology
Bristol-Myers Squibb Company (BMY) total-return data from January 2023 through the latest month-end close (2026-08-).
The entry price is the 2022 December month-end close and the exit is the latest available month-end close, both from adjusted (split and dividend) Yahoo Finance historical data.
Month-end resolution, no taxes or fees, and history never guarantees the future. For exact-date precision (including buying at a panic low), use the BMY calculator page.
Compute your own BMY scenario
Data: Yahoo Finance. As of 2026-08-. Not financial advice.